Teva Pharmaceutical Industries (TEVA) Insider Trading & Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free teva Stock Alerts $13.01 +0.13 (+1.01%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Teva Pharmaceutical Industries (NYSE:TEVA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.55%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$5.93 M Get TEVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Teva Pharmaceutical Industries stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TEVA Insider Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Teva Pharmaceutical Industries Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/5/2024Mark SabagEVPSell100,000$13.52$1,352,000.00 2/28/2024Eric DrapeVPSell9,815$13.12$128,772.80 2/28/2024Vikki L ConwayInsiderSell1,366$13.12$17,921.92 2/16/2024Eric DrapeVPSell173,261$13.05$2,261,056.05 2/15/2024Richard D FrancisCEOSell74,530$13.15$980,069.50 2/1/2024Amir WeissCAOSell31,766$12.37$392,945.42 8/7/2023Eliyahu Sharon KalifCFOSell35,125$9.73$341,766.25 8/4/2023Amir WeissCAOSell1,981$9.92$19,651.52 8/1/2023Eric A. HughesinsiderSell52,742$8.30$437,758.60 (Data available from 1/1/2013 forward) TEVA Insider Trading Activity - Frequently Asked Questions Who is on Teva Pharmaceutical Industries's Insider Roster? The list of insiders at Teva Pharmaceutical Industries includes Amir Weiss, David Matthew Stark, Eli Shani, Eliyahu Sharon Kalif, Eric A. Hughes, Eric Drape, Hafrun Fridriksdottir, Mark Sabag, Richard D Francis, Sven Dethlefs, and Vikki L Conway. Learn more on insiders at TEVA. What percentage of Teva Pharmaceutical Industries stock is owned by insiders? 0.55% of Teva Pharmaceutical Industries stock is owned by insiders. Learn more on TEVA's insider holdings. Which Teva Pharmaceutical Industries insiders have been selling company stock? The following insiders have sold TEVA shares in the last 24 months: Amir Weiss ($412,596.94), David Matthew Stark ($1,316,407.02), Eliyahu Sharon Kalif ($900,651.25), Eric A. Hughes ($437,758.60), Eric Drape ($2,389,828.85), Hafrun Fridriksdottir ($1,068,600.00), Mark Sabag ($1,352,000.00), Richard D Francis ($980,069.50), Sven Dethlefs ($782,183.10), and Vikki L Conway ($17,921.92). How much insider selling is happening at Teva Pharmaceutical Industries? Insiders have sold a total of 883,133 Teva Pharmaceutical Industries shares in the last 24 months for a total of $9,658,017.18 sold. More Insider Trading Tools from MarketBeat Related Companies: VTRS Insider Selling BGNE Insider Selling KRTX Insider Selling BMRN Insider Selling SRPT Insider Selling UTHR Insider Selling ALNY Insider Selling CTLT Insider Selling GMAB Insider Selling ITCI Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NYSE:TEVA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
